Johnson Matthey’s JV in China Completes Construction of API Plant

Aoxing Pharmaceutical (Shijiazhuang, China) says its previously announced Hebei Aoxing API Pharmaceutical joint venture with Johnson Matthey has recently completed construction of its newly renovated facility, which focuses on research, development, and manufacturing of active pharmaceutical ingredients (API) of narcotics and neurological drugs for the Chinese market. The jv is located in the Hebei Aoxing campus at Xinle, China. Full GMP certification from the State Food and Drug Administration (SFDA; Beijing) and a pharmaceutical business license is expected by...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers